Santaris, BMS in RNA discovery deal

Santaris Pharma A/S (Horsholm, Denmark) and Bristol-Myers Squibb Co. (NYSE:BMY) partnered to discover and develop RNA-targeted therapies for undisclosed indications using the biotech's Locked Nucleic ...